Regulation of caspases by nitric oxide

被引:85
作者
Kim, PKM
Kwon, YG
Chung, HT
Kim, YM
机构
[1] Kangwon Natl Univ, Vasc Syst Res Ctr, Chunchon, South Korea
[2] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA
[3] Wonkwang Univ, Coll Med, Dept Immunol, Iksan, Chonbug, South Korea
[4] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Coll Med, Chunchon, South Korea
来源
NITRIC OXIDE: NOVEL ACTIONS, DELETERIOUS EFFECTS AND CLINICAL POTENTIAL | 2002年 / 962卷
关键词
nitric oxide; caspase; apoptosis; inflammation; iron;
D O I
10.1111/j.1749-6632.2002.tb04054.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nitric oxide can prevent or induce apoptosis depending on its concentration, cell type, and the oxidative milieu. Nitric oxide inhibits apoptosis and inflammation by S-nitrosylation of the active site cysteine of caspases, the central effector molecules of cell death as well as maturation of IL-1beta and IL-18. The ability of nitric oxide to S-nitrosylate caspases depends on multiple factors including the presence of free iron and intracellular redox potential. There are no known direct effects of nitric oxide on promoting caspase activation or activity. However, nitric oxide has been shown to promote apoptotic pathways in numerous cell types through the indirect activation of caspases. In this article we review the relationship of nitric oxide and caspase activity, modulation of this effect by iron, and clinical implications for the use of nitric oxide in regulating inflammation and apoptosis.
引用
收藏
页码:42 / 52
页数:11
相关论文
共 74 条
[11]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[12]   Nitric oxide as a bioregulator of apoptosis [J].
Chung, HT ;
Pae, HO ;
Choi, BM ;
Billiar, TR ;
Kim, YM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (05) :1075-1079
[13]   Nitric oxide and iron proteins [J].
Cooper, CE .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :290-309
[14]   Protective effect of deferoxamine on sodium nitroprusside-induced apoptosis in PC12 cells [J].
Desole, MS ;
Sciola, L ;
Sircana, S ;
Godani, C ;
Migheli, R ;
Delogu, MR ;
Piras, G ;
De Natale, G ;
Miele, E .
NEUROSCIENCE LETTERS, 1998, 247 (01) :1-4
[15]   Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases [J].
Dimmeler, S ;
Haendeler, J ;
Nehls, M ;
Zeiher, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :601-607
[16]  
Dimmeler S, 1998, CELL GROWTH DIFFER, V9, P415
[17]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[18]   GENETIC-CONTROL OF PROGRAMMED CELL-DEATH IN THE NEMATODE C-ELEGANS [J].
ELLIS, HM ;
HORVITZ, HR .
CELL, 1986, 44 (06) :817-829
[19]   Interleukin-18 and interleukin-1β:: Two cytokine substrates for ICE (Caspase-1) [J].
Fantuzzi, G ;
Dinarello, CA .
JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (01) :1-11
[20]   NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines [J].
Fiorucci, S ;
Santucci, L ;
Antonelli, E ;
Distrutti, E ;
Del Sero, G ;
Morelli, O ;
Romani, L ;
Federici, B ;
Del Soldato, P ;
Morelli, A .
GASTROENTEROLOGY, 2000, 118 (02) :404-421